These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14141891)

  • 1. CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIC WOMEN: COMPARISON OF DIFFERENTIAL EFFECTS ON VARIOUS PSYCHOLOGICAL MODALITES DURING AND AFTER TREATMENT.
    RAY TS; RAGLAND RE; CLARK ML
    J Nerv Ment Dis; 1964 Apr; 138():348-53. PubMed ID: 14141891
    [No Abstract]   [Full Text] [Related]  

  • 2. DISCONTINUATION OR REDUCTION OF CHEMOTHERAPY IN CHRONIC SCHIZOPHRENICS.
    CAFFEY EM; DIAMOND LS; FRANK TV; GRASBERGER JC; HERMAN L; KLETT CJ; ROTHSTEIN C
    J Chronic Dis; 1964 Apr; 17():347-58. PubMed ID: 14141840
    [No Abstract]   [Full Text] [Related]  

  • 3. A DOUBLE-BLIND COMPARISON OF THIORIDAZINE AND CHLORPROMAZINE.
    STABENAU JR; GRINOLS DR
    Psychiatr Q; 1964 Jan; 38():42-63. PubMed ID: 14148394
    [No Abstract]   [Full Text] [Related]  

  • 4. TIME-SERIES, FREQUENCY ANALYSIS, AND ELECTROGENESIS OF THE EEGS OF NORMALS AND PSYCHOTICS BEFORE AND AFTER DRUGS.
    PFEIFFER CC; GOLDSTEIN L; MURPHREE HB; SUGERMAN AA
    Am J Psychiatry; 1965 Jun; 121():1147-55. PubMed ID: 14286047
    [No Abstract]   [Full Text] [Related]  

  • 5. The evaluation of chlorpromazine therapy in chronic schizophrenic women. A replicated experiment.
    Ragland R; Clark ML; Ray TS; Paredes A; Costiloe JP; Segal B; Wolf S
    J Chronic Dis; 1968 Oct; 21(6):445-60. PubMed ID: 4879902
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients.
    Spiegel DE; Keith-Spiegel P
    J Nerv Ment Dis; 1967 Feb; 144(2):111-6. PubMed ID: 5338760
    [No Abstract]   [Full Text] [Related]  

  • 7. Chlorpromazine in women with chronic schizophrenia: the effect on cholesterol levels and cholesterol-behavior relationships.
    Clark ML; Ray TS; Paredes A; Ragland RE; Costiloe JP; Smith CW; Wolf S
    Psychosom Med; 1967; 29(6):634-42. PubMed ID: 5582955
    [No Abstract]   [Full Text] [Related]  

  • 8. FACTORS INFLUENCING THE CLINICAL RESPONSES OF SCHIZOPHRENIC PATIENTS TO PHENOTHIAZINE DRUGS AND TO PLACEBO.
    KLERMAN GL; DAVIDSON EM; KAYCE MM
    Psychiatr Res Rep Am Psychiatr Assoc; 1964 Dec; 19():97-115. PubMed ID: 14232660
    [No Abstract]   [Full Text] [Related]  

  • 9. COMMUNICATION OF BODY COMPLAINTS AND PARANOID SYMPTOM CHANGE UNDER CONDITIONS OF PHENOTHIAZINE TREATMENT.
    FREEDMAN N; ENGELHARDT D; MANN D; MARGOLIS R; LONDON S
    J Pers Soc Psychol; 1965 Apr; 1():310-8. PubMed ID: 14328737
    [No Abstract]   [Full Text] [Related]  

  • 10. A CLINICAL COMPARISON OF TRIFLUPERIDOL, HALOPERIDOL, AND CHLORPROMAZINE.
    FOX W; GOBBLE IF; CLOS M; DENISON E
    Curr Ther Res Clin Exp; 1964 Jun; 6():409-15. PubMed ID: 14200303
    [No Abstract]   [Full Text] [Related]  

  • 11. COMPUTER ANALYSIS OF DRUG EFFECTS ON THE ELECTROENCEPHALOGRAMS OF NORMAL AND PSYCHOTIC SUBJECTS.
    MURPHREE HB; GOLDSTEIN L; PFEIFFER CC; SCHRAMM LP; JENNEY EH
    Int J Neuropharmacol; 1964 Apr; 3():97-104. PubMed ID: 14334603
    [No Abstract]   [Full Text] [Related]  

  • 12. Observations of placebo response in chronic schizophrenic patients.
    Bishop MP; Gallant DM
    Arch Gen Psychiatry; 1966 May; 14(5):497-503. PubMed ID: 5326295
    [No Abstract]   [Full Text] [Related]  

  • 13. A TYPOLOGY OF CHILDREN'S PSYCHIATRIC DISORDERS. I. ITS APPLICATION TO A CONTROLLED EVALUATION OF TREATMENT.
    FISH B; SHAPIRO T
    J Am Acad Child Psychiatry; 1965 Jan; 4():32-52. PubMed ID: 14267867
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of oxypertine and chlorpromazine in chronic schizophrenia.
    Goldberg GJ; Brooke G; Townsend HR; Brahma RK; Hill GB
    Acta Psychiatr Scand; 1970; 46(2):126-35. PubMed ID: 4920718
    [No Abstract]   [Full Text] [Related]  

  • 15. PERSONALITY FACTORS IN VARIABILITY OF RESPONSE TO PHENOTHIAZINES.
    HENINGER G; DIMASCIO A; KLERMAN GL
    Am J Psychiatry; 1965 May; 121():1091-4. PubMed ID: 14283305
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the behavioral effects of periodic administration of chlorpromazine and a "sustained-release" form of chlorpromazine.
    Orzack MH; Taylor CL; Kornetsky C
    Clin Pharmacol Ther; 1969; 10(2):258-64. PubMed ID: 4887298
    [No Abstract]   [Full Text] [Related]  

  • 17. Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group.
    Arch Gen Psychiatry; 1968 Apr; 18(4):482-95. PubMed ID: 4868797
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECTS OF CHLORPROMAZINE AND IMIPRAMINE ON SYSTOLIC BLOOD PRESSURE IN PSYCHIATRIC PATIENTS: RELATIONSHIPS TO AGE, DIAGNOSIS AND INITIAL BLOOD PRESSURE.
    BLUMBERG AG; KLEIN DF; POLLACK M
    J Psychiatr Res; 1964 Jan; 2():51-60. PubMed ID: 14113975
    [No Abstract]   [Full Text] [Related]  

  • 19. ARE TRANQUILIZER COMBINATIONS MORE EFFECTIVE THAN A SINGLE TRANQUILIZER?
    TALBOT DR
    Am J Psychiatry; 1964 Dec; 121():597-600. PubMed ID: 14239465
    [No Abstract]   [Full Text] [Related]  

  • 20. Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.
    Michaux MH; Kurland AA; Agallianos DD
    Curr Ther Res Clin Exp; 1966 Mar; 8(3):Suppl:117-52. PubMed ID: 4956162
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.